Placebo-Controlled Trial of Sertraline in the Treatment of Binge Eating Disorder
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors' goal was to assess the efficacy of sertraline in the treatment of binge eating disorder. METHOD: Thirty-four outpatients with DSM-IV binge eating disorder were randomly assigned to receive either sertraline (N=18) or placebo (N=16) in a 6-week, double-blind, flexible-dose (50-200 mg) study. Except for response level, outcome measures were analyzed by random regression methods, with treatment-by-time interaction as the effect measure. RESULTS: Compared with placebo, sertraline was associated with a significantly greater rate of reduction in the frequency of binges, clinical global severity, and body mass index as well as a significantly greater rate of increase in clinical global improvement. Patients receiving sertraline who completed the study demonstrated a higher level of response, although the effect was not significant. CONCLUSIONS: In a 6-week trial, sertraline was effective and well tolerated in the treatment of binge eating disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820020059008 · Cited by 371
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Psychological treatment of eating disorders.
Wilson, G. T., Grilo, C. M., & Vitousek, K. M. (2007) · American Psychologist · doi:10.1037/0003-066x.62.3.199 · Cited by 645
Wilfley, D. E., Welch, R. R., Stein, R. I., Spurrell, E. B., Cohen, L. R., Saelens, B. E., Dounchis, J. Z., Frank, M. A., Wiseman, C. V., & Matt, G. E. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.8.713 · Cited by 603
Binge eating disorder and obesity
de Zwaan, M. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801699 · Cited by 522
McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Rosenthal, N. R., Karim, M. R., Kamin, M., & Hudson, J. I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.255 · Cited by 484
Self-citationBinge eating disorder treatment: a systematic review of randomized controlled trials
Brownley, K. A., Berkman, N. D., Sedway, J. A., Lohr, K. N., & Bulik, C. M. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20370 · Cited by 346
Vocks, S., Tuschen‐Caffier, B., Pietrowsky, R., Rustenbach, S. J., Kersting, A., & Herpertz, S. (2010) · International Journal of Eating Disorders · doi:10.1002/eat.20696 · Cited by 343
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2162 · Cited by 322
Self-citationMeta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder
Hilbert, A., Petroff, D., Herpertz, S., Pietrowsky, R., Tuschen-Caffier, B., Vocks, S., & Schmidt, R. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000358 · Cited by 283
Review of sertraline and its clinical applications in psychiatric disorders
McRae, A. L., & Brady, K. T. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.5.883 · Cited by 287
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis
Brownley, K. A., Berkman, N. D., Peat, C. M., Lohr, K. N., Cullen, K. E., Bann, C. M., & Bulik, C. M. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2455 · Cited by 285
McElroy, S. L., Hudson, J. I., Capece, J. A., Beyers, K., Fisher, A. C., & Rosenthal, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.008 · Cited by 281
Self-citationAigner, M., Treasure, J., Kaye, W., Kasper, S., & The WFSBP Task Force on Eating Disorders (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.602720 · Cited by 207
“McElroy et al. (2007b) conducted a 10-week randomized placebo controlled double blind, single centre with 40 patients.”
MethodGrilo, C. M., & Masheb, R. M. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.11.010 · Cited by 199
Binge eating disorder: Disorder or marker?
Stunkard, A. J., & Allison, K. C. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10210 · Cited by 119
Rapid response to treatment for binge eating disorder
Grilo, C. M., Masheb, R. M., & Wilson, G. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.3.602 · Cited by 117
Night Eating Syndrome: Diagnosis, Epidemiology and Management
O???Reardon, J. P., Peshek, A., & Allison, K. C. (2005) · CNS Drugs · doi:10.2165/00023210-200519120-00003 · Cited by 100
Ghaderi, A., Odeberg, J., Gustafsson, S., Råstam, M., Brolund, A., Pettersson, A., & Parling, T. (2018) · PeerJ · doi:10.7717/peerj.5113 · Cited by 79
Pharmacological approaches to the management of binge eating disorder
Brownley, K. A., Peat, C. M., La Via, M., & Bulik, C. M. (2015) · Drugs · doi:10.1007/s40265-014-0327-0 · Cited by 78
“1 Antidepressants Five different selective serotonin reuptake inhibitors (SSRIs) have been studied over active treatment periods ranging from 6 to 52 weeks: these include citalopram (60 mg/day) [80], escitalopram (30 mg/day) [81], fluoxetine (80 mg/day) [82], fluoxetine (60 mg/day) [83–86], fluvoxamine (300 mg/day) [8…”
BackgroundPharmacological management of binge eating disorder: current and emerging treatment options
McElroy, S., Guerdjikova, A. I., Mori, N., & O’Melia, A. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s25574 · Cited by 74
Self-citationCurrent and emerging drug treatments for binge eating disorder
Reas, D. L., & Grilo, C. M. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.879291 · Cited by 52
“In a 6-week RCT, sertraline was associated with significantly greater reduction in binge eating and weight loss, but not binge eating remission or depression [40].”
The Treatment of Obesity and Its Co-Occurrence With Substance Use Disorders
VanBuskirk, K. A., & Potenza, M. N. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181ce38e7 · Cited by 48
Pharmacotherapy of Eating Disorders
Jackson, C. W., Cates, M., & Lorenz, R. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610362239 · Cited by 28
Amodeo, G., Cuomo, A., Bolognesi, S., Goracci, A., Trusso, M. A., Piccinni, A., Neal, S. M., Baldini, I., Federico, E., Taddeucci, C., et al. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1571041 · Cited by 25
Treatment of Binge Eating Disorder
Crow, S. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0023-4 · Cited by 8
Metadata
- Authors
- McElroy, S. L., Casuto, L. S., Nelson, E. B., Lake, K. A., Soutullo, C. A., Keck, P. E., & Hudson, J. I.
- Venue
- American Journal of Psychiatry
- Published
- 2000-06-01
- Volume
- 157
- Issue
- 6
- Pages
- 1004-1006
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2150331112
- Cited by
- 170
- References
- 1
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.